Norway· NO-ID_19B62C55-224D-46BE-A082-82D2F0F6266B

Copneg

A neostigmin, kombinationen product containing glycopyrronium bromide + neostigmine metilsulfate, registered in Norway by EQL Pharma AB. The same ATC class is registered in 6 of our 19 countries.

ATC N07AA51

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCopnegATCN07AA51REGISTER NO.NO-ID_19B62C55-224D-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Neostigmin, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC N07AA51 (neostigmin, kombinationen), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 4 of them publish a price we can compare per daily dose

Neostigmin, kombinationen · ATC N07AA51

6 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Glycopyrronium Bromide + Neostigmine Metilsulfate
Manufacturer
EQL Pharma AB
Country
Norway (NO)
ATC code
N07AA51
ATC class
Neostigmin, Kombinationen
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_19B62C55-224D-46BE-A082-82D2F0F6266B
  • no_varenummer
    448144
    10 x 1
    NOK 532.2
  • gtin
    7350099992322

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Neostigmin, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neostigmin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Combistig
  • Belgium · Robinul-Neostigmine
  • Denmark · Copneg, Robinul-Neostigmin
  • Estonia · Glynex
  • Finland · Copneg, Glycostigmin
  • United Kingdom (Northern Ireland) · Glycopyrrolate And Neostigmine Metilsulfate Mercury Pharmaceuticals Ltd,, Glycopyrronium Bromide And Neostigmine Metilsulfate Martindale Pharmaceuticals
  • Croatia · Novistig
  • Hungary · Novistig
  • Ireland · Glycopyrronium Bromide And Neostigmine Metilsulfate Mercurypharm, Novistig
  • Luxembourg · Robinul-Neostigmine
  • Poland · Novistig
  • Sweden · Copneg, Robinul
  • Slovenia · Novistig

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/210ac11e-a03b-4aaf-80dc-639973d0e822
GET /v1/drugs/210ac11e-a03b-4aaf-80dc-639973d0e822?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Neostigmin, kombinasjoner",
  "merkevare_id": "ID_19B62C55-224D-46BE-A082-82D2F0F6266B",
  "name_form_strength": "Copneg inj, oppl 0,5 mg/ml/2,5 mg/ml",
  "prescription_group": "C"
}

See everything about neostigmin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.